TLRY

Tilray Brands, Inc.

NasdaqAdd to watchlist

Healthcare · Drug Manufacturers—Specialty & Generic

$4.57

−$0.02−0.44%

Delayed · 2026-08-31T20:00:00.000Z · marketstack

1 open-market sale on file ($233K), none of them under a pre-arranged plan. Who, and when

Aug 24, 2026$4.57

−$0.15−3.18%over 1M

Session

Day range54% of range

$4.50$4.63

Fundamentals

Visualize fundamentals and more

Market cap: 511.07M
P/E ratio: -

Revenue grew +11.46% in FY2028, +2.60% faster than its sector. The median across Healthcare companies this platform tracks is +8.87%.

Risk factors, year on year

Item 1AJul 2026 10-KJul 2025

added: 18
dropped: 19
re-drafted: 17

Out of 164 passages in this year’s Item 1A.

New this year

In the United States, despite cannabis having been legalized at the state level for medical use in many states and for adult-use in a number of states, marijuana remains subject to significant federal regulation under the Controlled Substances Act, or the …

36 more passages are on Bespoke

Bespoke Create a free account

Free, no card, and it does not expire. See what the paid plans add

What it says it is exposed to

From Item 1A of its most recent 10-K, filed July 2026.

Product recalls
Litigation
Crypto
Tax
Currency moves
Debt covenants
Goodwill impairment
FDA approval

And 20 more.

Product recalls
Manufacturers and distributors of cannabis, hemp and beverage products are sometimes subject to the recall or return of their products for a variety of reasons, including product defects, such as contamination, adulteration, unintended harmful side effects or …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Recent activity

Sep 14 Unregistered share sale Company filing 8-K
Aug 10 Unregistered share sale Company filing 8-K
Aug 4 Merton Carl A bought 10,000 shares Insider trading Form 4 Chief Financial Officer, about $46k

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Updated Sep 14, 2026 · the newest SEC filing on file

Tilray Brands, Inc. investor relations

What TLRY has filed with the SEC. This is not Tilray Brands, Inc.’s own investor relations site: these filings are the primary source that site publishes from.

Companies like Tilray Brands, Inc.

Also filed under Drug Manufacturers, ranked by how closely they sit beside TLRY.

LLYELI LILLY & Cocompare with TLRY
JNJJohnson & Johnsoncompare with TLRY
AMGNAmgen Inc.

What it says it is exposed to

From Item 1A of its most recent 10-K, filed July 2026.

Product recalls
Litigation
Crypto
Tax
Currency moves
Debt covenants
Goodwill impairment
FDA approval

And 20 more.

Product recalls
Manufacturers and distributors of cannabis, hemp and beverage products are sometimes subject to the recall or return of their products for a variety of reasons, including product defects, such as contamination, adulteration, unintended harmful side effects or …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

MRKMerck & Co., Inc.compare with TLRY

BMYBristol Myers Squibb Co.compare with TLRY

Ask about Tilray Brands, Inc.

The assistant answers from what TLRY has actually filed: 13 annual reports filed with the SEC, 46 Form 4 filings from the last year and 2 funds that hold it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Press one and the answer appears right here on the page, from TLRY's filings and figures. One a day without an account; a free account has its own, and no card.

See how much of Tilray Brands, Inc. each of these investors holds, and every quarter they moved.

Ten seconds. No card. Nothing to cancel.

No card, no broker connection.

Continue with Google

What an account lets you do with Tilray Brands, Inc.

Be told the moment a TLRY insider trades
Put Tilray Brands, Inc. on a watchlist for a free alert, the bell and a daily email, when a Form 4 worth a row is filed, with vesting and automatic tax sales already struck out so what lands is a decision, not paperwork.
The full filing historyMeasure
Ask what growth the price is already betting on
Tilray Brands, Inc.'s income statement, balance sheet and cash flow as filed, and the ratios computed from them, plus a reverse DCF that holds today's price fixed and solves for the growth it requires.
The reverse DCFMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: how big a bet each one is, and by how much it changed.
Every position, sizedMeasure
Interrogate the filing, not the internet
Ask anything about Tilray Brands, Inc.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free account See what the paid plans add

Free, no card, and it does not expire.

Recent activity

Sep 14 Unregistered share sale Company filing 8-K
Aug 10 Unregistered share sale Company filing 8-K
Aug 4 Merton Carl A bought 10,000 shares Insider trading Form 4 Chief Financial Officer, about $46k

22 more events are on Measure

Free, no card, and it does not expire. See what the paid plans add

Risk factors, year on year

Item 1AJul 2026 10-KJul 2025

added: 18
dropped: 19
re-drafted: 17

Out of 164 passages in this year’s Item 1A.

New this year

In the United States, despite cannabis having been legalized at the state level for medical use in many states and for adult-use in a number of states, marijuana remains subject to significant federal regulation under the Controlled Substances Act, or the …

36 more passages are on Bespoke

Bespoke Create a free account

Free, no card, and it does not expire. See what the paid plans add